Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Gastrin I in Human GI Research: Evidence and Limits
2026-10-05
Gastrin I is relevant to research on CCK2-linked gastric signaling and acid secretion, but the supplied organoid study does not directly test the peptide. This overview separates supplier-described biology from peer-reviewed findings on hiPSC-derived intestinal organoids, clarifies conceptual applications, and defines the limits of translating intestinal pharmacokinetic models into gastric physiology or therapeutic claims.
-
TRPV1 Modulation in Metastatic Breast Cancer
2026-10-05
This 2021 Life Sciences study examined how TRPV1 modulation alters cytokine responses in mice bearing distinct metastatic breast carcinoma subtypes. Its central finding is that TRPV1 agonism produced different, and sometimes adverse, immune effects in tumor-bearing versus control animals, highlighting the importance of disease context when interpreting TRPV1 pharmacology.
-
Berberine and Evodiamine Modulate GERD via TRPV1
2026-10-04
A 2024 Phytomedicine study reports that berberine and evodiamine reduced esophageal injury and inflammatory responses in rat and cell models of gastroesophageal reflux disease. Its main innovation is a mechanistic framework linking TAS2R38 and TRPV1 to MAPK/NF-κB signaling, epithelial barrier preservation, and macrophage-polarization changes.
-
Triacetin Digestion and Hepatic Metabolic Signaling
2026-10-03
A 2025 rat study shows that triacetin, a short-chain triacylglycerol, is digested in the upper gastrointestinal tract and absorbed mainly as acetate and glycerol. The findings connect triacetin-derived metabolites with hepatic AMPK signaling and gene-expression changes, while highlighting important limits for translation to human nutrition and metabolic disorder research.
-
hiPSC Intestinal Organoids for Pharmacokinetics
2026-10-02
Saito and colleagues establish an accessible 3D culture strategy for generating expandable human iPSC-derived intestinal organoids that retain differentiation potential after propagation and cryopreservation. When transferred to 2D monolayers, the organoids produce intestinal epithelial cells with enterocyte-associated metabolic and transporter activities, creating a practical human-relevant platform for pharmacokinetic research.
-
CB-839 (Telaglenastat): Assay Reliability Guide
2026-10-01
This scenario-based guide explains how CB-839 (Telaglenastat), SKU B4799, can support controlled glutaminase 1 inhibition studies, viability assays, and cancer metabolism research. It connects formulation, dose-response design, PRMT5-linked glutamine biology, and practical vendor-selection criteria while distinguishing established evidence from testable hypotheses.
-
RG108 Pharmacokinetics in Rats: Study Analysis
2026-10-01
The reference study evaluated the in vivo pharmacokinetics and tissue distribution of RG108, a non-nucleosidic DNA methyltransferase inhibitor, after subcutaneous administration in rats. Its findings show that RG108 reaches micromolar plasma and tissue concentrations, supporting its use as an experimental DNA demethylation agent while also emphasizing the importance of exposure, metabolism, and formulation in translational studies.
-
Primary Antibody Dilution Buffer for PCNSL
2026-09-30
Learn how Primary Antibody Dilution Buffer K1200 can support spatial validation of PCNSL single-cell findings. This guide connects buffer chemistry, tissue accessibility, assay controls, and the limits of inferring SLC2A5 biology from IHC, ICC, and ISH.
-
Anti-ROR1 Antibody in Liver Injury Research
2026-09-30
Explore how Anti-ROR1 Antibody (Zilovertamab) can serve as a mechanistic probe at the intersection of ROR1 cancer biology and DON-induced liver injury. This evidence-aware guide emphasizes species validation, pathway controls, assay selection, and translational limitations.
-
Murine RNase Inhibitor for RNA Integrity
2026-09-29
Murine RNase Inhibitor protects RNA workflows through selective, oxidation-resistant inhibition of pancreatic-type RNases. This article connects that biochemical design to assay decisions inspired by recent ASCC3–FMRP research in fragile X syndrome models.
-
TMRE and Mitochondrial Potential: From Signal to Insight
2026-09-29
A translational framework for using Tetramethylrhodamine ethyl ester perchlorate to connect mitochondrial membrane potential with caspase-3/NDUFS1-driven oxidative injury in trichothecene research.
-
Nigericin Sodium Salt: Practical Assay Guide
2026-09-28
Nigericin sodium salt is a potassium ionophore for controlled K+/H+ exchange, membrane ion transport, and ionic-context studies. This guide covers preparation, short pilot exposures, platelet aggregation modulation, and lead (Pb2+) ion transport while defining limits for interpretation, clinical use, and unsupported dose extrapolation.
-
Berberine–Evodiamine Signaling in GERD
2026-09-28
A 2024 study found that berberine and evodiamine improved esophageal injury and inflammatory readouts in rat and cell models of gastroesophageal reflux disease. Its mechanistic contribution is to connect TAS2R38 and TRPV1 signaling with MAPK/NF-κB activity, epithelial barrier markers, and macrophage polarization, while using genetic and pharmacological interventions to test that pathway.
-
DAPI Nuclear Stain Solution: Practical Workflow
2026-09-27
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution provides a ready-to-use fluorescent DNA stain for visualizing nuclei and supporting endpoint cell viability or apoptosis workflows. Its limited cell permeability makes it better suited to fixed or membrane-compromised samples than intact live-cell imaging, and staining alone cannot establish apoptosis or viability conclusively.
-
RTX and the Next Layer of TRPV1 Pain Biology
2026-09-26
Resiniferatoxin offers translational researchers a powerful way to probe TRPV1-positive sensory neurons. New findings on cholesterol-dependent membrane organization add an important experimental layer: receptor activation and the neuronal context that shapes it should be studied together.